SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-24-000021
Filing Date
2024-05-09
Accepted
2024-05-09 09:01:55
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20240331.htm   iXBRL 10-Q 1698503
2 EX-31.1 rprx-20240331ex311.htm EX-31.1 9252
3 EX-31.2 rprx-20240331ex312.htm EX-31.2 9288
4 EX-32 rprx-20240331ex32.htm EX-32 5009
  Complete submission text file 0001802768-24-000021.txt   8319321

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20240331.xsd EX-101.SCH 63205
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20240331_cal.xml EX-101.CAL 81146
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20240331_def.xml EX-101.DEF 349979
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20240331_lab.xml EX-101.LAB 675099
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20240331_pre.xml EX-101.PRE 479082
76 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20240331_htm.xml XML 1234011
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 24928906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)